BACKGROUND: A key challenge to mining electronic health records for mammography research is the preponderance of unstructured narrative text, which strikingly limits usable output. The imaging characteristics of breast cancer subtypes have been described previously, but without standardization of parameters for data mining. METHODS: The authors searched the enterprise-wide data warehouse at the Houston Methodist Hospital, the Methodist Environment for Translational Enhancement and Outcomes Research (METEOR), for patients with Breast Imaging Reporting and Data System (BI-RADS) category 5 mammogram readings performed between January 2006 and May 2015 and an available pathology report. The authors developed natural language processing (NLP) software algorithms to automatically extract mammographic and pathologic findings from free text mammogram and pathology reports. The correlation between mammographic imaging features and breast cancer subtype was analyzed using one-way analysis of variance and the Fisher exact test. RESULTS: The NLP algorithm was able to obtain key characteristics for 543 patients who met the inclusion criteria. Patients with estrogen receptor-positive tumors were more likely to have spiculated margins (P 5.0008), and those with tumors that overexpressed human epidermal growth factor receptor 2 (HER2) were more likely to have heterogeneous and pleomorphic calcifications (P 5.0078 and P 5.0002, respectively). CONCLUSIONS: Mammographic imaging characteristics, obtained from an automated text search and the extraction of mammogram reports using NLP techniques, correlated with pathologic breast cancer subtype. The results of the current study validate previously reported trends assessed by manual data collection. Furthermore, NLP provides an automated means with which to scale up data extraction and analysis for clinical decision support.
INTRODUCTION
Breast cancer continues to be one of the leading causes of cancer death among women in the United States. 1 Advances have been made in the identification of prognostic and predictive markers for breast cancer treatment. Biomarker expression data are stored in the patient's electronic health record (EHR). Established molecular markers, including the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), are currently used to help guide treatment with targeted therapies such as antiestrogen and anti-HER2 therapies. 2, 3 Mammography is the first step in the screening and diagnosis of breast cancer. Abnormal mammographic findings such as a mass, abnormal calcifications, architectural distortion, and asymmetric density can lead to a cancer diagnosis. The use of mammography data for translational research primarily is hindered by variations in mammographic reporting and the preponderance of unstructured narrative text, which limit data collection and interpretation.
The American College of Radiology developed the Breast Imaging Reporting and Data System (BI-RADS) lexicon to standardize mammographic reporting to facilitate cancer risk communication and biopsy decision making. 4 The BI-RADS lexicon includes 43 descriptors and classifies mammograms into 1 of 7 assessment categories. 4 Despite the BI-RADS recommendations, substantial interobserver variability in the application of the BI-RADS lexicon remains, including inappropriate term usage and missing data. [5] [6] [7] [8] [9] In addition, the majority of data are not collected in a structured format as defined by Digital Imaging and Communications in Medicine (DICOM) structured reporting, 10 and still are reported as free text in accessible media such as mammographic reporting systems or radiology information systems.
Traditional mammographic imaging research has used manual abstraction to convert information from the free text report into structured data. Manual abstraction is not feasible for large sample sizes due to limitations of time as well as expense. In the era of EHR systems, big data, and machine learning algorithms, natural language processing (NLP) has emerged as a possible solution with which to overcome the limitations of manual data abstraction and creates great opportunities in data mining of breast imaging to facilitate outcomes research and precision medicine. NLP is a component of artificial intelligence and uses algorithms to process data patterns to make information accessible.
11 Public domain and commercial NLP systems have been tested extensively in research and clinical settings. [11] [12] [13] [14] [15] [16] [17] [18] The study institution uses the PowerScribe radiology dictation system (Nuance Communications Inc, Burlington, Mass), which does not allow for structured reports. Because commercial NLP systems are not readily available for academic and affiliated hospitals implementing breast cancer decision support systems, we developed an NLP-based tool, the Methodist Hospital text teaser (MOTTE). MOTTE is able to extract data reliably from millions of free text mammogram reports archived in our enterprise clinical data warehouse. 19 Several retrospective studies and meta-analyses have described the associations between specific tumor subtypes and mammographic features by using manual record entry. [20] [21] [22] [23] [24] [25] [26] [27] The purpose of the current study was to investigate the usefulness of data mining and NLP in defining the set of mammographic features correlated with the molecular subtypes of breast cancer in women with BI-RADS category 5 mammogram reports.
MATERIALS AND METHODS

Data Source and Study Design
The current study was approved by the Institutional Review Board of the Houston Methodist Hospital, where all study patients underwent mammography and biopsy.
Clinical data were sourced from the Methodist Environment for Translational Enhancement and Outcomes Research (METEOR) data warehouse. 19 METEOR is an enterprise-wide clinical data warehouse and analytics environment that integrates an existing business data warehouse with internal and external research databases and national registries to support clinical research and outcomes studies for improving the cost-effectiveness of patient care. METEOR evaluates data queries and has the ability to process clinical free text documents and perform advanced analytics and visualization reporting. The METEOR data warehouse contains records dating back to January 1, 2006 from approximately 2 million unique patients with visit encounter and clinical records. In particular, the METEOR data warehouse contains 135,280 unique patient mammogram reports dating from January 1, 2006 to May 30, 2015 . Breast biopsy and pathologic data also were obtained from METEOR.
MOTTE, the online structured query language processing tool with NLP capability, was used to identify patients with BI-RADS category 5 mammograms who underwent breast biopsy within 3 months of their abnormal mammogram report date between January 2006 and May 2015. A Java-based NLP tool was then developed and used to parse out the sentences from the reports to exclude the note section. A total of 717 patients with BI-RADS category 5 mammograms were identified. Without a formal chart review of all the records, there may have been additional BI-RADS category 5 mammograms that were not included. Next, patients with invasive cancer were identified among this pool of 717 patients using our MOTTE NLP tool and applying major keywords for invasive carcinoma and subtype information (ER, PR, and HER2 status) from the pathology textual reports. Of the 717 patients, 543 patients were found to have invasive disease and were included in the current study. MOTTE was used to extract clinical data (age, race, height, weight, body mass index [BMI] , and personal and family history of breast cancer) from the METEOR data warehouse. For patients who had undergone surgery within 3 months of the date of their abnormal mammogram, pathologic information (tumor stage and ER, PR, and HER2 status) was extracted by applying NLP to the biopsy and surgical pathology reports. Mammographic findings were extracted using statistical database queries; International Classification of Diseases, Ninth Revision (ICD 9) codes; and MOTTE, which included clinical symptoms such as palpable lump, skin changes, and nipple discharge as well as breast density as a categorical variable and the presence of a mass, calcifications, architectural distortion, asymmetric density, and calcification characteristics as categorical variables.
MOTTE NLP Analysis
To facilitate NLP analysis, text reports were preprocessed by determining the general structure of each of the radiology or pathology reports. NLP was then applied to search and retrieve established clinical parameters. MOTTE's NLP algorithm contains 5 processing steps including tokenization, stemming, stop words removal, vector space modeling, and similarity calculation, as detailed in our previous publication. 19 Tokenization turns each clinical text report into a stream of tokens. We used a Bayesian model and defined token "t" as a string of alphanumeric characters surrounded by white space. The second step adopted was stemming. A word in a different grammatical form was converted into the word's ground form using the stem class model to remove the phase affixes and other lexical components and then refreshed as the new token. For example, we converted the words diagnosing, diagnoses, and diagnosed into diagnose. The third step involved removing stop words. Stop words do not carry any useful information for the text report analysis and usually are conjunctions, pronouns, or prepositions such as the, this, and which. We defined the list of stop words based on prior publications. 18 The next processing step adopted was the modeling of all tokens in a high-dimensional vector space. We defined each token as a dimension of the vector space and the frequency of each token occurring in each sentence as the position along the axis in the vector space. Hence, each token has different axis positions for different sentences. The similarity between the requested clinical information and the sentence was measured in terms of distances in this vector space.
Similarity calculation was the final step in the METEOR's MOTTE tool. We set up a series of clinical information key points according to the requirements of physicians and researchers and then calculated the similarity between the key points and each sentence. We used the Jaccard similarity coefficient to compare the similarity and diversity of sample sets, 16 with the highest Jaccard similarity coefficient among all sentences selected as the return value. For example, one of our clinical information items was complex cystic mass and in the free text report, the sentence "there is a new complex cystic mass with internal septations" contained the highest Jaccard similarity coefficient, indicating a positive finding.
The free text radiology and pathology reports of the 543 patients with invasive cancer were reviewed and predefined parameters were extracted by applying NLP MOTTE techniques. We used the approach described by Buckley et al, 28 including creating a bucket list of keywords of interest and negation, merging addendum pathology reports, and ordering of diagnosis based on the level of significance (invasive ductal carcinoma, invasive lobular carcinoma>ductal carcinoma in situ [DCIS]> atypical lobular hyperplasia>atypical ductal hyperplasia>benign). 28 Invasive carcinoma was identified using the following major keywords: //Carcinoma invasive carcinoma, tubular carcinoma, invasive, invasive ductal carcinoma, invasive lobular carcinoma, infiltrating, infiltrating ductal carcinoma, infiltrating lobular carcinoma, infiltrating tubular carcinoma, adenocarcinoma, necrotic carcinoma, and infiltrative. In addition, variations in the above keywords (arising majorly from misspellings) were included in the bucket list of keywords. Multiple pathology reports from the same individual were reported as an addendum to the initial report. The MOTTE program merged all the addendums with the initial report and then processed this single report. In cases in which >1 stage of disease was reported in the merged reports, the MOTTE program selected the higher stage. MOTTE was not programmed to distinguish between multiple excisions on the same side or bilateral excisions. Resulting data were verified and validated (99% accuracy) by assessing a random 10% of records 29 against a gold standard of manual chart review, which was completed by the clinical coauthors and took approximately 50 to 70 hours. Furthermore, manual review also was performed for the 174 patients not included in the current study and confirmed the NLP findings. NLP accurately identified 174 charts as having incomplete information (HER2 status) for subtype determination or benign biopsy findings.
Molecular Subtype Categories
Patients were divided into 3 established breast cancer prognostic groups based on tumor biomarker expression. Tumors with ER expression >1% by immunohistochemistry (IHC) and negative HER2 expression by IHC and/ or fluorescence in situ hybridization were categorized as ER positive (ER1). Tumors with HER2 overexpression, defined as IHC 3 1 or fluorescence in situ hybridization amplified as per the American Society of Clinical Oncology/College of American Pathologists guidelines, 3 were categorized as HER2 positive (HER21) regardless of ER or PR expression. Tumors with negative ER, PR, and HER2 expression were categorized as triple-negative breast cancer (TNBC).
Statistical Analysis
Breast cancer subtypes were correlated with demographic and mammographic features. Differences in categorical Original Article and continuous factors among the breast cancer subtypes were analyzed using the Fisher exact test and one-way analysis of variance, respectively. The Tukey-Kramer method was used for post hoc pairwise comparisons of continuous factors. All offline statistical analyses were performed using SAS statistical software (version 9.4; SAS Institute Inc, Cary, NC) at a 5% significance level (2-sided).
RESULTS
Study Population
A total of 717 patients with BI-RADS category 5 mammograms were identified. The MOTTE NLP algorithm was applied to mammogram and pathology reports using major keywords for invasive carcinoma and to extract information regarding the breast cancer subtype (ER, PR, and HER2 status). Of the 717 patients, 543 (75.7%) had invasive carcinoma and breast cancer subtype available. MOTTE-generated data from these patients were used to determine the correlation of demographic, clinical, and mammographic characteristics with breast cancer subtype. Table 1 shows the frequency of individual BI-RADS lexicon in the reports. Manual review (ER, PR, and HER2 status; BMI; and breast density) was performed for a subset of the 543 patients (10%) to confirm NLP accuracy. Characteristics of the study population are shown in Table 2 . Sixty patients with DCIS and therefore unknown HER2 status (HER2 testing is not performed for patients with DCIS at the study institution), 35 patients with benign breast biopsies, 4 patients with atypia, and 75 patients who did not have available pathology reports were excluded from the study. The mean age of the patients was 60.9 years (range, 59.7-62 years). With regard to the breast cancer subtype, 70.7%, 15.8%, and 13.4% of patients, respectively, had ER 1 breast cancer, HER2 1 breast cancer, and TNBC.
Differences in Demographic Factors Among the Breast Cancer Subtypes
Age at diagnosis was significantly different among patients with the 3 subtypes (P 5 .03) ( Table 3 ). The mean age at diagnosis was lowest in the patients with HER2 1 disease and highest among those with ER 1 disease.
Data regarding BMI were available for 73.5% of the patients. The mean BMI was 28.9 (range, 28.4-29.5), indicating that the majority of patients were overweight. BMI was not found to be significantly different among the 3 subtypes; however, the group of patients with TNBC had the highest mean BMI (P 5 .08) ( Table 3) .
The majority of patients were white (67%), followed by African American (17%), Asian (4.7%), and Hispanic (1.3%) ( Table 2 ). The percentage of patients with TNBC tended to be higher in the African American group than in the other racial groups, but this difference was not statistically significant (P 5 .06) ( Table 4) .
Approximately 62% of patients were postmenopausal ( Table 2 ). The distribution of breast cancer subtypes did not appear to differ significantly according to menopausal status (P 5 .0640) (Table 3) . However, postmenopausal women were more likely to have the ER 1 and TNBC breast cancer subtypes and less likely to have the HER2 1 subtype compared with premenopausal women.
Only 6.8% of patients had a previous history of breast cancer (Table 2) . Approximately 70% of patients had no family history of breast cancer, which is consistent with historical numbers. Personal and family histories of breast cancer were not associated with breast cancer subtype (Table 3) .
Differences in Clinical Characteristics Among the Breast Cancer Subtypes
Approximately 44% of patients presented with a palpable lump, and patients with HER2 1 and TNBC tumors were twice as likely to present with a palpable lump compared with patients with ER 1 tumors (P<.0001) ( Table 3 ) (Fig. 1) . Skin changes were present in <25% of the patients. Skin changes were twice as likely to be present in patients with the HER2 1 subtype compared with those with the ER 1 and TNBC subtypes (P<.0001) ( Table 3 ) (Fig. 1) . Nipple discharge was observed infrequently (1.1%), thereby prohibiting significant differences among the subtypes.
Differences in Mammographic Features Among the Breast Cancer Subtypes
Breast density was > 25% in 91.6% of patients ( Table 2) . The most common breast density was fibroglandular (density of 25%-50%), followed by heterogeneous density (density of 51%-75%). Breast density did not appear to differ significantly among the subtypes (P 5 .5917) ( Table 3) . Nearly all patients (97.8%) had a mass present on their mammogram. The presence of a mass on mammography was not significantly different among the subtypes. Nearly one-half of patients had spiculated margins, and those with the ER 1 subtype were 1.5 times as likely to have spiculated margins compared with patients with the HER2 1 and TNBC subtypes (P 5 .0008) ( Table 3 ) (Fig. 2) . Approximately 68% of patients had calcifications present in their tumors. Calcifications were more likely to be present in patients with the HER2 1 subtype compared with those with the ER 1 and TNBC subtypes (P 5 .05) ( Table 3) . With regard to calcification morphology, the occurrence of heterogeneous, linear, and pleomorphic calcifications was significantly higher in patients with the HER2 1 subtype compared with those with the ER 1 and TNBC subtypes (P 5 .008, .004, and .0002, respectively) ( Table 3) (Fig. 2) . Linearly distributed calcifications were observed in a negligible number of patients. Segmentally distributed and clustered calcifications demonstrated a trend toward increased occurrence in patients with the HER2 1 subtype (P 5 .16 and .17, respectively) ( Table 3) .
Architectural distortion and axillary lymphadenopathy were noted in 18.6% and 37.2% of patients, respectively (Table 2) . Although not statistically significant, architectural distortion was more likely to be associated with the ER 1 subtype (P 5 .12) ( Table 3) . Axillary lymphadenopathy was more likely to be associated with the HER2 1 and TNBC subtypes compared with the ER 1 subtype (P<.0001) ( Table 3) (Fig. 1) .
Differences in Pathologic Stage Among the Breast Cancer Subtypes
Data regarding pathologic stage were available for 257 patients who underwent surgery within 3 months of biopsy. Patients who received neoadjuvant chemotherapy before surgery were not included in the staging analysis. Pathologic disease stage did not appear to differ significantly among the subtypes (Table 3) .
DISCUSSION
We have developed an NLP tool that automatically and accurately extracts mammographic findings from a large number of free text reports. A previous study using the METEOR database as well as MOTTE found an acceptable range of accuracy (96.4%). 19 Various NLP techniques have been used to extract clinically useful information from mammography reports. However, to the best of our knowledge, the current study is the first to use NLP to characterize mammographic characteristics according to breast cancer subtype such that the correlation can be used to aid more robust clinical decisions.
Previous studies have conducted manual chart reviews to describe the correlation between mammographic findings and biomarkers. 22, 23, 30 In the current study, NLP was used to confirm and validate previously reported correlations. Specifically, we found that patients with the ER 1 subtype were more likely to present with spiculated margins than those with the HER2 1 and TNBC subtypes. Spiculated margins are believed to be secondary to the intense stromal reaction and fibroblastic proliferation observed in ER 1 tumors. Spiculated margins are less common in TNBCs, which demonstrate a more infiltrative tumor growth. Patients with HER2 1 tumors were more likely to present with heterogeneous, linear, and pleomorphic calcifications. Calcification is postulated to be secondary to rapid growth and central necrosis.
The strength of the current study was the large volume of free text reports from a relevant patient population captured in the enterprise data warehouse of the study institution and the use of NLP and data mining for automated data extraction, collection, and correlation. The NLP algorithm of MOTTE surpasses the manual method for information extraction in terms of consistency, time, cost, and data preparation. NLP may provide an accurate automated system with which to create large-scale data repositories of breast imaging findings and malignancies for use in data mining in breast imaging. Secondary studies are planned to apply our NLP algorithm to define distinct characteristics of BI-RADS category 4 mammograms. Such studies would help to refine biopsy recommendations, thereby decreasing health care costs and morbidity.
The current study was limited by the fact that it was conducted at a single institution to assess the performance of a single NLP algorithm. As a result, some of the descriptors in the BI-RADS lexicon, especially those describing the distribution of calcifications, were not frequently used. The use of BI-RADS terminology will improve the ease of use and accuracy of the NLP application. Another limitation was that the MOTTE program was not coded to distinguish between multiple excisions on the same side and bilateral excisions. Our future plan is to modify the evaluations to allow the MOTTE program to differentially extract excisional location (left side vs right side). Finally, our sample size was determined by the population of patients who underwent biopsy at the study institution, which may have potentially introduced an ascertainment bias into the analysis.
Conclusions
The current retrospective review of mammographic characteristics based on information extracted from diagnostic reports using the MOTTE NLP algorithm demonstrated that mammographic features can be used to distinguish breast cancer subtypes. NLP algorithms can narrow the gap between the unstructured clinical reports and the detailed information extraction needed for data mining and decision support tools. Future studies to apply MOTTE to create a predictive model to drive evidence-based biopsy decision making in clinical practice currently are underway. Clinical findings found to be significantly correlated with breast cancer subtype. Axillary lymphadenopathy was more likely to be associated with the human epidermal growth factor receptor 2-positive (HER21) and triplenegative breast cancer (TNBC) subtypes. A palpable lump was more likely to be noted with the TNBC and HER2 1 subtypes compared with the estrogen receptorpositive (ER1) subtype. Skin changes were more likely to be observed among patients with the HER2 1 subtype compared with those with the ER 1 and TNBC subtypes. Figure 2 . Mammographic findings found to be significantly correlated with breast cancer subtype. Heterogeneous, linear, and pleomorphic calcifications were more likely to be observed with the human epidermal growth factor receptor 2-positive (HER21) subtype compared with the estrogen receptor-positive (ER1) and triple-negative breast cancer (TNBC) subtypes. Spiculated margins occurred more frequently in patients with the ER 1 subtype compared with those with the HER2 1 and TNBC subtypes.
